4.6 Article

What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?

期刊

JOURNAL OF NEUROSURGERY
卷 108, 期 1, 页码 92-96

出版社

AMER ASSOC NEUROLOGICAL SURGEONS
DOI: 10.3171/JNS/2008/108/01/0092

关键词

mosaic mutation; neurofibromatosis Type 2; unilateral vestibular schwannoma

向作者/读者索取更多资源

Object. Individuals who develop a unilateral vestibular schwannoma (VS) and other neurogenic tumors are at high risk of having the inherited condition neurofibromatosis Type 2 (NF2). The risk of bilateral disease and transmission risk to offspring are important in surgical planning and counseling. The authors have attempted to resolve these risks. Methods. A large NF2 dataset was interrogated for individuals who had initially presented with a unilateral VS and other tumors before developing bilateral disease, to assess the contralateral and offspring risks. Results. Ninety-six patients with a unilateral VS and additional neurogenic tumors had a bilaterality rate of 48% at 20 years in those initially diagnosed when > 18 years of age and 82% if presenting earlier. Constitutional NF2 mutations were found in blood in 25 (27%) of 92, but 13 (76%) of 17 patients presenting with unilateral VS at : IS years of age. Tumor analysis suggests that the vast majority of the remainder are mosaic for an NF2 mutation. Conclusions. Patients with unilateral VS and other NF2-related tumors who fulfill Manchester criteria have a high risk of developing a contralateral tumor, especially if presenting in childhood. Transmission risks are reduced for offspring, particularly in the older patients who are likely to be mosaic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Genetics & Heredity

Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancers

D. Gareth Evans, Siva Sithambaram, Elke Maria van Veen, George J. Burghel, Helene Schlecht, Elaine F. Harkness, Helen Byers, Jamie M. Ellingford, Ashu Gandhi, Sacha J. Howell, Anthony Howell, Claire Forde, Fiona Lalloo, William G. Newman, Miriam Jane Smith, Emma Roisin Woodward

Summary: This study aimed to investigate the frequency of germline pathogenic variants (PVs) in women with ductal carcinoma in situ (DCIS) and grade 1 invasive breast cancer (G1BC). The results showed that DCIS was more likely to be associated with both BRCA1/2 and non-BRCA1/2 PVs than G1BC. Extended panel testing is recommended for young-onset DCIS where PV detection rates are highest.

JOURNAL OF MEDICAL GENETICS (2023)

Letter Oncology

RE: Heterozygous BRCA1/BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer

D. Gareth Evans, Emma R. Woodward

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes

Jose Garcia-Pelaez, Rita Barbosa-Matos, Silvana Lobo, Alexandre Dias, Luzia Garrido, Sergio Castedo, Sonia Sousa, Hugo Pinheiro, Liliana Sousa, Rita Monteiro, Joaquin J. Maqueda, Susana Fernandes, Fatima Carneiro, Nadia Pinto, Carolina Lemos, Carla Pinto, Manuel R. Teixeira, Stefan Aretz, Svetlana Bajalica-Lagercrantz, Judith Balmana, Ana Blatnik, Patrick R. Benusiglio, Maud Blanluet, Vincent Bours, Hilde Brems, Joan Brunet, Daniele Calistri, Gabriel Capella, Sergio Carrera, Chrystelle Colas, Karin Dahan, Robin de Putter, Camille Desseignes, Elena Dominguez-Garrido, Conceicao Egas, D. Gareth Evans, Damien Feret, Eleanor Fewings, Rebecca C. Fitzgerald, Florence Coulet, Maria Garcia-Barcina, Maurizio Genuardi, Lisa Golmard, Karl Hackmann, Helen Hanson, Elke Holinski-Feder, Robert Huneburg, Mateja Krajc, Kristina Lagerstedt-Robinson, Conxi Lazaro, Marjolijn J. L. Ligtenberg, Cristina Martinez-Bouzas, Sonia Merino, Genevieve Michils, Srdjan Novakovic, Ana Patino-Garcia, Guglielmina Nadia Ranzani, Evelin Schrock, Ines Silva, Catarina Silveira, Jose L. Soto, Isabel Spier, Verena Steinke-Lange, Gianluca Tedaldi, Maria-Isabel Tejada, Emma R. Woodward, Marc Tischkowitz, Nicoline Hoogerbrugge, Carla Oliveira

Summary: This study analyzed families carrying rare CDH1 variants, comparing the cancer spectrum in carriers of pathogenic or likely pathogenic variants (PV/LPV) or missense variants of unknown significance, and evaluated the performance of expanded criteria for CDH1 testing. The results showed that PV/LPV carriers were positively associated with lobular breast cancer, diffuse gastric cancer, and gastric cancer, while missense variants of unknown significance did not show this positive association.

LANCET ONCOLOGY (2023)

Review Medicine, General & Internal

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

Charlotte Carton, D. Gareth Evans, Ignacio Blanco, Reinhard E. Friedrich, Rosalie E. Ferner, Said Farschtschi, Hector Salvador, Amedeo A. Azizi, Victor Mautner, Claas Roehl, Sirkku Peltonen, Stavros Stivaros, Eric Legius, Rianne Oostenbrink

Summary: This study aims to integrate information on NF1-associated tumors to assist healthcare professionals in tumor surveillance of NF1 individuals. Personalized and targeted tumor management proposals have been defined to ensure appropriate care for those in need.

ECLINICALMEDICINE (2023)

Review Obstetrics & Gynecology

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations

Denise R. Nebgen, Susan M. Domchek, Joanne Kotsopoulos, Joanne A. de Hullu, Emma J. Crosbie, Vincent Singh Paramanandam, Monique Brood van Zanten, Barbara M. Norquist, Theresa Guise, Serge Rozenberg, Allison W. Kurian, Holly J. Pederson, Nese Yuksel, Rachel Michaelson-Cohen, Sharon L. Bober, Agnaldo Lopes da Silva, Nora Johansen, F. Guidozzi, D. Gareth Evans, Usha Menon, Sheryl A. Kingsberg, C. Bethan Powell, Giovanni Grandi, Claudia Marchetti, Michelle Jacobson, Donal J. Brennan, Martha Hickey

Summary: Women with high inherited risk of ovarian cancer can undergo risk-reducing salpingo-oophorectomy (RRSO) between the ages of 35 and 45. While RRSO can save lives, it can also cause symptoms that negatively impact quality of life and long-term health. This scoping review explores the effects of RRSO on short- and long-term health and provides evidence-based international consensus recommendations for comprehensive care.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Article Oncology

Randomised controlled trial of breast cancer and multiple disease prevention weight loss programmes vs written advice amongst women attending a breast cancer family history clinic

Michelle Harvie, David P. French, Mary Pegington, Cheryl Lombardelli, Suzy Krizak, Katharine Sellers, Emma Barrett, D. Gareth Evans, Ramsey Cutress, Andrea Wilding Rgn, Lee Graves, Anthony Howell

Summary: This study compared the efficacy of two remotely delivered weight loss programs and written advice. The results showed that both weight loss programs resulted in more women achieving a weight loss of ≥10%, but there was no evidence of additional benefits from the multiple disease prevention program. Therefore, a multicenter RCT is warranted to test the weight loss program across breast cancer Family History, Risk and Prevention Clinics in the UK.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study

Robert D. Morgan, Andrew R. Clamp, Bethany M. Barnes, Kirsten Timms, Helene Schlecht, Laura Yarram-Smith, Yvonne Wallis, Mikel Valganon-Petrizan, Suzanne MacMahon, Rhian White, Sian Morgan, Sarah McKenna, Emma Hudson, Laura Tookman, Angela George, Ranjit Manchanda, Sudha S. Sundar, Shibani Nicum, James D. Brenton, Rebecca S. Kristeleit, Susana Banerjee, Iain A. McNeish, Jonathan A. Ledermann, Stephen S. Taylor, D. Gareth R. Evans, Gordon C. Jayson

Summary: This study reports data from the first year of routine homologous recombination deficiency testing in the NHS in England, Wales, and Northern Ireland, demonstrating the significant survival benefits of olaparib plus bevacizumab maintenance therapy in women with newly diagnosed, advanced, high-grade ovarian cancer.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Editorial Material Genetics & Heredity

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1

Nicola Flaum, Emma J. Crosbie, Emma Roisin Woodward, Fiona Lalloo, Robert Morgan, Neil Ryan, D. Gareth Evans

JOURNAL OF MEDICAL GENETICS (2023)

Article Genetics & Heredity

TP53 c.455C>T p.(Pro152Leu) pathogenic variant is a lower risk allele with attenuated risks of breast cancer and sarcoma

D. Gareth Evans, Elaine F. Harkness, Emma R. Woodward

Summary: Germline TP53 variants, particularly the p.R337H and p.P152L, are associated with different cancer risks in Li-Fraumeni syndrome. The p.P152L variant is mainly linked to childhood adrenal tumors and has lower risks for non-adrenal tumors compared to the p.R337H variant. Understanding codon-specific cancer risks is crucial for individualized risk assessment and prevention strategies in LFS.

JOURNAL OF MEDICAL GENETICS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Automatic assessment of mammographic density using a deep transfer learning method

Steven Squires, Elaine Harkness, Dafydd Gareth Evans, Susan M. Astley

Summary: This study aims to build automated models using deep learning based on the scores given by radiologists to predict mammographic breast density accurately and consistently. The approach involves using pretrained deep networks to generate feature vectors for regression analysis, and the results show that the model performs at a similar level to human experts in estimating cancer risk. The study also demonstrates the high consistency and potential of the model.

JOURNAL OF MEDICAL IMAGING (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

The effect of variable labels on deep learning models trained to predict breast density

Steven Squires, Elaine F. Harkness, D. Gareth Evans, Susan M. Astley

Summary: High breast density is associated with reduced efficacy of mammographic screening and increased breast cancer risk. Accurate automated density estimates can be used for risk prediction. However, expert reader assessments of density show variation and this variability affects the model's mapping from representation to prediction.

BIOMEDICAL PHYSICS & ENGINEERING EXPRESS (2023)

Article Psychology, Clinical

How do women at increased risk of breast cancer make sense of their risk? An interpretative phenomenological analysis

Victoria G. Woof, Lorna McWilliams, Anthony Howell, D. Gareth Evans, David P. French

Summary: This study aimed to gain an in-depth understanding of women's lived experiences of receiving an increased breast cancer risk. The findings suggest that providing risk predictions has little impact on women's beliefs about breast cancer risk, and discussions with healthcare professionals are needed to help women form more accurate appraisals and make informed decisions.

BRITISH JOURNAL OF HEALTH PSYCHOLOGY (2023)

Article Clinical Neurology

The comparable tumour microenvironment in sporadic and NF2-related schwannomatosis vestibular schwannoma

Grace E. Gregory, Adam Paul Jones, Michael J. Haley, Christopher Hoyle, Leo A. H. Zeef, I-Hsuan Lin, David J. Coope, Andrew T. King, D. Gareth Evans, Pawel Paszek, Kevin N. Couper, David Brough, Omar N. Pathmanaban

Summary: Bilateral vestibular schwannoma is a characteristic feature of NF2-related schwannomatosis, which is associated with multiple surgical interventions, radiotherapy, and off-label use of bevacizumab. Unilateral vestibular schwannoma occurs sporadically in non-NF2-related schwannomatosis patients without drug treatment options. Tumour-infiltrating immune cells, especially macrophages and T-cells, play a role in the growth of vestibular schwannoma and show similarities between sporadic and NF2-related schwannomatosis tumours. However, there are differences in tumour presentation and patient characteristics between these two conditions. This study compared the tumour microenvironment of sporadic and NF2-related schwannomatosis vestibular schwannoma and found strong similarities in the immune profiles.

BRAIN COMMUNICATIONS (2023)

Article Oncology

Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

Karin M. Kast, Esther L. John, John Hopper, Nadine Andrieu, Catherine Nogues, Emmanuelle Mouret-Fourme, Christine Lasset, Jean-Pierre Fricker, Pascaline Berthet, Veronique Mari, Lucie K. Salle, Marjanka Schmidt, Margreet G. E. M. Ausems, Encarnacion B. Gomez Garcia, Irma R. van de Beek, Marijke Wevers, D. Gareth Evans, Marc Tischkowitz, Fiona Lalloo, Jackie Cook, Louise Izatt, Vishakha Tripathi, Katie Snape, Hannah Musgrave, Saba Sharif, Jennie V. Murray, Sarah V. Colonna, Irene L. Andrulis, Mary B. Daly, Melissa C. Southey, Miguel de la Hoya, Ana Osorio, Lenka Foretova, Dita Berkova, Anne-Marie Gerdes, Edith Olah, Anna Jakubowska, Christian F. Singer, Yen Tan, Annelie Augustinsson, Johanna Rantala, Jacques Simard, Rita K. Schmutzler, Roger L. Milne, Kelly-Anne Phillips, Mary Beth Terry, David Goldgar, Flora E. van Leeuwen, Thea M. Mooij, Antonis C. Antoniou, Douglas F. Easton, Matti A. Rookus, Christoph Engel

Summary: The study found that height, body mass index (BMI), and weight gain are associated with breast cancer risk in the general population. It is unclear whether these associations also exist for carriers of pathogenic variants in the BRCA1 or BRCA2 genes.

BREAST CANCER RESEARCH (2023)

Article Health Care Sciences & Services

Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program

Stuart J. Wright, Martin Eden, Helen Ruane, Helen Byers, D. Gareth Evans, Michelle Harvie, Sacha J. Howell, Anthony Howell, David French, Katherine Payne

Summary: This study identified and quantified the resource use and associated costs of introducing a breast cancer risk-stratification approach into the English national breast screening program. Findings showed that using questionnaires and automated breast density measurement for risk prediction had low costs, but adding SNP testing significantly increased the costs.

MDM POLICY & PRACTICE (2023)

暂无数据